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The 1.2 Å crystal structure of hirustasin reveals the intrinsic
flexibility of a family of highly disulphide-bridged inhibitors
Isabel Usón1, George M Sheldrick1, Eric de La Fortelle2, Gerard Bricogne2†,
Stefania Di Marco3‡, John P Priestle3, Markus G Grütter3§ and Peer RE Mittl3§*
Background: Leech-derived inhibitors have a prominent role in the
development of new antithrombotic drugs, because some of them are able to
block the blood coagulation cascade. Hirustasin, a serine protease inhibitor
from the leech Hirudo medicinalis, binds specifically to tissue kallikrein and
possesses structural similarity with antistasin, a potent factor Xa inhibitor from
Haementeria officinalis. Although the 2.4 Å structure of the hirustasin–kallikrein
complex is known, classical methods such as molecular replacement were not
successful in solving the structure of free hirustasin.
Results: Ab initio real/reciprocal space iteration has been used to solve the
structure of free hirustasin using either 1.4 Å room temperature data or 1.2 Å
low temperature diffraction data. The structure was also solved independently
from a single pseudo-symmetric gold derivative using maximum likelihood
methods. A comparison of the free and complexed structures reveals that
binding to kallikrein causes a hinge-bending motion between the two hirustasin
subdomains. This movement is accompanied by the isomerisation of a cis
proline to the trans conformation and a movement of the P3, P4 and P5
residues so that they can interact with the cognate protease. 
Conclusions: The inhibitors from this protein family are fairly flexible despite
being highly cross-linked by disulphide bridges. This intrinsic flexibility is
necessary to adopt a conformation that is recognised by the protease and to
achieve an optimal fit, such observations illustrate the pitfalls of designing
inhibitors based on static lock-and-key models. This work illustrates the
potential of new methods of structure solution that require less or even no prior
phase information.
Introduction
The saliva of leeches contains a variety of peptidic
inhibitors that are crucial for food uptake and digestion.
Many of these inhibitors prevent blood coagulation or
platelet aggregation, which makes them attractive for the
treatment of thrombosis and other cardiovascular diseases.
Four closely related protease inhibitors, hirustasin, antis-
tasin, ghilanten and guamerin, have been isolated from dif-
ferent leeches [1–4]. Hirustasin, a highly disulphide-bridged
55 amino acid inhibitor, was purified from the medical leech
Hirudo medicinalis. Hirustasin inhibits the protease tissue
kallikrein, but not plasma kallikrein, plasmin, factor Xa or
trypsin. The disulphide connectivity as well as the overall
structure and binding mode of this inhibitor were rec-
ently established by the structure analysis of the hirus-
tasin–kallikrein complex [5]. Although the inhibitor consists
of only 55 residues, the structure suggests that it is divided
into two subdomains, one of which is involved in kallikrein
binding. The related inhibitor antistasin was isolated from
the Mexican leech Haementeria officinalis and contains a
twofold internal repeat [2,6]. A sequence identity of 30%
between hirustasin and antistasin implied a similar three-
dimensional structure, which was proven by the structure
determination of the uncomplexed inhibitor [7]. Antistasin
reversibly inhibits factor Xa and shows antithrombotic activ-
ity in various in vivo models for thrombosis. Apart from its
anticoagulant activity, antistasin is able to suppress metasta-
sis, possibly also via the inhibition of factor Xa [2,8].
Herein we describe the crystal structure of free hirustasin
at 1.2 Å resolution. The structure was not amenable to the
conventional methods of structure solution, like molecular
replacement or standard single isomorphous replacement
with anomalous scattering (SIRAS) phasing. The compari-
son of the free and complexed hirustasin structures reveals
that the N- and C-terminal subdomains are flexible. Upon
binding to the cognate protease, synergistic structural
changes occur in the protease and in the inhibitor.
Results and discussion
After initial attempts to solve the structure of hirustasin
by SIRAS ran into difficulties, on account of the 
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near-pseudo-symmetry of the gold atomic position, the
two approaches described below were initiated simulta-
neously and pursued independently.
Structure solution ab initio
The structure of hirustasin was solved in a few pentium
hours by a new ab initio method [9] using the 1.2 Å low tem-
perature synchrotron data. This method was inspired by the
Shake and Bake approach of Miller et al. [10,11]. Like
Shake and Bake, the method is based on real/reciprocal
space recycling, but there are many differences in detail.
Starting from a trial set of random atoms, phases are refined
by the tangent formula [12] in reciprocal space, alternating
with the elimination of potential atoms in real space [13] to
maximise Σ Ec2(Eo2–1) for the largest E values. In addition,
chemical knowledge may be incorporated. In this case use
was made of the knowledge that ten sulphur atoms must be
present as five disulphide bonds; possible solutions were
screened by checking for the presence of at least three pairs
of atoms among the strongest peaks in the list, with dis-
tances around 2.05 Å within each pair. Whenever this con-
dition was fulfiled, a figure of merit (PATFOM) was
calculated based on the Patterson superposition minimum
function [14]. For the solutions with either the best correla-
tion coefficient [15] or the best PATFOM so far, the peak
list was optimised from bottom to top [13] eliminating
atoms whenever this led to an improvement in the correla-
tion coefficient between observed and calculated nor-
malised structure factors, based on all data.
After 700 random trials (each consisting of five real/recip-
rocal space iterations for E > 1.4, followed — for poten-
tially correct solutions only — by six cycles of peak list
optimisation using all E values) a solution with a correla-
tion coefficient of 0.758 (best false solution 0.587) was
obtained. Two thirds of the 400 protein atoms had been
correctly identified, including nine of the ten sulphur
atoms. The presence of the five disulphide bonds as well
as the tight crystal packing facilitates structure solution
because it makes part of the structure very rigid. In
general, the atoms found in the ab initio solution were
those with the lowest B values.
The same strategy applied to the 1.4 Å room temperature
data also leads to the correct location of the sulphur atoms,
although a model as complete as with the 1.2 Å data
cannot be built up, assigning the remaining atoms directly
from the peak list. Even in the absence of the high-resolu-
tion data, the resulting electron-density maps are perfectly
interpretable by standard protein methods.
Figure 1 shows a stereo projection of the structure high-
lighting the part that was recognisable in the first 1.2 Å
solution. Figures 2a–c show the ab initio map, sigma-A
map [16] after B-value refinement of the unexpurgated
first solution and final sigma-A map. The quality of the
ab initio maps is striking when one bears in mind that they
are generated in an automatic computational procedure
from the native data alone; as no assumptions about
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Figure 1
Stereoview of the hirustasin structure. Atoms
located in the ab initio solution with 1.2 Å low
temperature data are coloured orange
(sulphur atoms) or green (carbon, oxygen or
nitrogen atoms). Some residue numbers and
the N and C termini are marked.
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protein structure have been made, they are entirely free of
‘model bias’. This is one of the largest structures solved so
far by pure direct methods, and illustrates the enormous
progress in the last couple of years and the potential of
such methods for solving small, tightly packed proteins.
Structure solution with a single pseudo-symmetric gold
derivative
The data employed for SIRAS* (SIRAS in combination
with maximum likelihood formalism) structure solution
are summarised in Table 1 and consist of the native data
from two crystals, referred to as native 1 (277K, 1.4 Å) and
native 2 (100K, 1.2 Å), and a gold derivative (277K, 2.3 Å).
The native 1 data set was first used truncated to 2.3 Å, to
match the outer resolution of the derivative data set, and
will be referred to as native 1 truncated.
The initial calculations were performed on the derivative
data set and the native 1 truncated data set. A Patterson
synthesis had been used to calculate the coordinates for 
a unique gold site at x = 0.081, y = 0.094, z = 0.004
(fractional), corresponding to X = 3.095 Å, Y = 3.588 Å,
Z = 0.303 Å (orthogonal), which is close to the twofold
crystallographic axis x = y, z = 0. The heavy-atom position
was refined as disordered about this position, in which
case there is ambiguity because of the severe overlap of
the Patterson peaks; instead of six independent Harker
peaks there are only two. Refinement with the program
SHARP [17] in space group P43212, converged to either of
two solutions corresponding to an inversion of sign of the
z coordinate of the single atom. The corresponding
refinements were performed in the enantiomeric space
group P41212, and again converged to only two solutions.
The statistics of the solvent-flattening procedure clearly
indicated that the correct space group was P43212, but
these statistics could not distinguish between the two
possible solutions in this space group.
The second data set was then included in the calculations.
Native 2 was not perfectly isomorphous to the 2.3 Å
native. Phase extension through envelope constraints only
(as there is only one molecule in the asymmetric unit) 
was performed using the solvent-flattening program
SOLOMON [18]. This was done with the two solutions
arising from the 2.3 Å calculation, and the statistics of the
solvent-flattening procedure clearly pointed to the right
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Figure 2
Residues 37–40 in the final model. (a) Fo map
from the ab initio solution based on the 1.2 Å
data. (b) Sigma-A weighted map [16]
calculated after refinement of the B values in
the unexpurgated 1.2 Å solution. (c) Sigma-A
weighted map [16] calculated after the final
refinement with 1.2 Å data. (d) SHARP
[17]/SOLOMON [18,19] Fo map calculated
with 1.2 Å data.
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solution. This resulted in a much improved electron-
density map, showing high-resolution detail, as well as
some degree of blurring arising from nonisomorphism.
Figure 2d shows the sigma-A map for the 1.2 Å data set in
the area of residues 37–40.
In contrast, the same phase-extension procedure using the
native 1 data set to its full resolution and the derivative data
set showed better detail in the final electron-density map,
although the resolution was nominally lower than with the
1.2 Å data because of the better isomorphism. As the gold
atom was very close to the special position (x = y; z = 0),
some reflections have heavy-atom structure-factor contribu-
tions close to zero. Envelope constraints exercised in direct
space through ‘solvent flipping’ in SOLOMON spread
phase information from well-phased reflections to badly
phased reflections and enabled the full reciprocal space
information to be recovered. Obtaining accurate phase
probability distributions for the poorly phased reflections
via maximum likelihood in SHARP was instrumental in the
success of this procedure. The application of MLPHARE
[19] was unsuccessful in deriving useful phase information.
The very low mean phase errors, shown as a function of
the resolution in Figure 3, underline the quality of the
SHARP/SOLOMON maps. The lower phase errors for
the 1.4 Å data are attributed to the more perfect isomor-
phism of the two room temperature data sets, and the rise
in the phase errors at high resolution is caused by the lack
of experimental phase information from the heavy-atom
derivative at high resolution. The ab initio phase errors,
also shown in Figure 3, do not have the benefit of the
derivative data and so, in general, are higher; however,
these phase errors show much less resolution dependence
and are better for the 1.2 Å than the 1.4 Å data, consistent
with the requirement of resolved atoms. In all four cases
the low mean phase errors correspond to immediately
interpretable maps.
Structure description and comparison of both models
Hirustasin contains 55 amino acid residues. In the crystal
structure derived from the 1.2 Å data, two N-terminal and
two C-terminal residues as well as the sidechain of Lys21
are not defined in the electron density and are missing in
the final model. The structure also contains 52 water mol-
ecules and a sulphate anion disordered between two sepa-
rate sites. Hirustasin is divided into two separate
58 Structure 1999, Vol 7 No 1
Figure 3
Mean phase error in degrees plotted against resolution for the ab initio
and SIRAS* solutions based on the 1.4 Å room temperature data and
1.2 Å low temperature data. The overall mean phase errors and map
correlation coefficients (in parentheses) are given for each method and
data set: ab initio 1.2 Å, 19° (0.87), ab initio 1.4 Å, 26° (0.81), SIRAS*
1.2 Å, 18° (0.89), and SIRAS* 1.4 Å, 13° (0.93). The final refined 1.2 Å
and 1.4 Å structures provided the reference phases.
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Table 1
Unit-cell parameters and data statistics.
Data set Native 1 Native 2 Au derivative
X-ray source EMBL (DESY, Hamburg)* SNBL* In-house
Wavelength (Å) 1.050 0.873 1.542
Temperature (K) 100 293 293
Derivative Native Native KAuCl4 (5 mM, 23 h)
Unit cell (Å) a = b = 37.77, c = 67.91 a = b = 38.33, c = 68.40 a = b = 38.28, c = 68.37
No. of unique reflections 15,928 10,508 2320
Multiplicity 2.4 6.8 2.7
Resolution (Å)† 1.2 (1.30–1.20) 1.4 (1.44–1.40) 2.3 (2.36–2.30)
Completeness (%)† 99.4 (98.1) 98.7 (97.7) 91.1 (87.3)
Rmerge† (%) 4.3 (37.6) 6.2 (17.4) 5.8 (9.3)
I/σ† 15.0 (1.6) 9.3 (3.4) 9.8 (8.2)
Riso (%) – – 27.8
*EMBL, European Molecular Biology Laboratory, Deutsches Elektronen Synchrotron (DESY); SNBL, Swiss Norwegian Beam Line at the European
Synchrotron Radiation Facility (ESRF), Grenoble, France. †Values in parentheses are for the highest resolution shell.
subdomains [5] and contains ten cysteine residues involved
in five disulphide bridges in an abab cdecde pattern [20]. The
N-terminal subdomain (residues 3–23) contains disulphide
bridges Cys6–Cys17 and Cys11–Cys22, and the C-terminal
subdomain (residues 24–53) contains disulphide bridges
Cys24–Cys44, Cys29–Cys48 and Cys33–Cys50. Intramole-
cular contacts take place only within each subdomain,
with the exception of a hydrogen bond between Asn25 N,
at the beginning of the C-terminal subdomain, and
Ala14 O in the N-terminal subdomain.
The crystals are very densely packed (Vm = 2.0 Å3/Da)
and nearly 40% of the water accessible surface of the
protein is covered by crystal contacts. The packing is
determined by four crystal contacts, which are sum-
marised in Table 2. Contact 1 involves the C-terminal
domains of two neighbouring molecules, which form a
tight dimer (Figure 4). This interaction is very large, cov-
ering 18.7% of the water accessible surface and containing
nine hydrogen bonds. The mainchains of residues 27–29
form an antiparallel β sheet with residues 29–27 of the
symmetry-equivalent molecule. These residues are situ-
ated at the beginning of the primary binding loop
(residues 26–32).
The model derived from the room temperature 1.4 Å res-
olution data lacks four residues at the N terminus and two
residues at the C terminus. The model contains only 37
water molecules. Otherwise, both models are very similar,
with a root mean square deviation (rmsd) of 0.66 Å for a
fit of all protein atoms and 0.30 Å for Cα atoms. The
largest differences involve the first four common residues
at the N terminus.
Structural changes upon binding to kallikrein
The crystal structure of hirustasin in complex with tissue
kallikrein was determined at 2.4 Å resolution [5]. In this
complex the primary binding loop from the C-terminal
subdomain (residues 26–32) is recognised by kallikrein. In
addition to the well known P3 to P2′ interactions,
kallikrein recognises the P4 (Val27) and P5 (Glu26)
residues of hirustasin. In particular, Val27 seems to be
important for proper binding because it interacts exten-
sively with the protease. The P4-binding pocket is absent
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Figure 4
Packing interactions between the C-terminal subdomains. The
N-terminal subdomains are depicted in yellow and the C-terminal
domains are in blue and green; β strands are shown as pink arrows.
The disulphide bridges are shown in ball-and-stick representation.
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Table 2
Crystal contacts of free hirustasin.
Contact number Symmetry* Contact area† (Å2) Polar interactions Distance (Å)
1 (–y, –x, 1/2 – z) 760 (18.7%) Cys24 N Cys33 O 2.9
(2/2/–1) Glu26 OE2 Arg32 NH1 2.5
Val27 N Cys29 O 3.1
Val27 O Cys29 N 2.9
His28 ND1 His28 ND1 2.7
Lys34 O Asn42 O 3.5
Tyr35 O Lys39 NZ 3.3
Leu37 N Glu45 OE2 3.2
Leu37 O Lys39 NZ 2.8
2 (1/2 + x, 1/2 – y, 1/4 – z) 460 (11.3%) Glu9 OE1 Lys38 NZ 2.8
(0/0/–1) Thr10 OG1 Ala51 O 2.8
Ala13 N Arg32 O 2.9
Arg30 N Glu41 OE2 2.8
Arg30 NH2 Pro47 O 2.8
Ile31 N Glu41 OE 3.1
3 (–y, –x, 1/2 – z) 220 (5.4%) Asn4 OD1 Gly7 N 2.7
(1/1/–1) Asn4 ND2 Thr5 O 2.7
4 (1/2 – y, 1/2 + x, 3/4 + z) 150 (3.7%) Glu26 OE1 SO4 101 O2 2.7
(1/–2/–1) Glu26 OE2 SO4 101 O2 2.9
*Crystallographic symmetry operator and translation vector. †Water accessible surface that is buried in the crystal as an absolute number and as a
fraction of the total water accessible surface of hirustasin (4070 Å2).
in the structure of a complex formed between kallikrein
and bovine pancreatic trypsin inhibitor (BPTI) [21].
Surprisingly for such a compact structure that is tightly
linked by five disulphide bridges, a superposition of the
free and bound forms of hirustasin yields an overall rmsd of
2.13 Å. The difference is due to a change in the backbone
conformation of residues 26–29 and 46–48 upon binding.
This distortion causes a different orientation of the C-ter-
minal subdomain with respect to the N-terminal subdo-
main. The interface between the two subdomains, which
in the complex is created by the sidechains of residues
12–15 and 40–46, is lost in the free hirustasin structure.
The rmsds resulting from the superposition (Figure 5) of
the individual subdomains are significantly lower (0.47 Å
for residues 5–23 and 0.51 Å for residues 30–45). Figure 6
shows a superposition based on the C-terminal subdo-
main. In the hirustasin–kallikrein structure the N-terminal
subdomain has rotated 35° relative to the C-terminal sub-
domain and the inhibitor achieves a more extended con-
formation than in the free form. Similar movements have
been observed for the N- and C-terminal domains of antis-
tasin [7]. The low rmsd for the superposition of the N-ter-
minal subdomain indicates that it moves as a rigid body
relative to the C-terminal subdomain, which undergoes a
more complex change. For the calculation of the rmsds
residues 24–29 were omitted, although these residues
were originally assigned to the C-terminal subdomain.
These residues form a short linker that connects the sub-
domains and is recognised by the protease. The rmsd of
1.6 Å for the superposition of this linker is substantially
larger than for other regions of the peptide, indicating a
major structural rearrangement within this fragment. In
the hirustasin–kallikrein complex the Val27 sidechain
points into a hydrophobic pocket in the cognate protease,
but in the structure of the unbound hirustasin it faces the
sidechain of Leu37 from the C-terminal subdomain
(Figure 7a). This movement is roughly equivalent to a
180° rotation of Val27 around its mainchain. The neigh-
bouring residues Glu26 and His28 undergo similar move-
ments. Residues 46–48 echo the reorientation of the short
linker, as residues 29 and 48 are cysteine residues bonded
to one another through a disulphide bridge. Pro47 adopts a
cis conformation in the free hirustasin and a trans confor-
mation in the complexed structure. Given the fact that
residues 24–29 are covalently linked to the core of 
the C-terminal subdomain by disulphide bridges,
Cys24–Cys44 and Cys29–Cys48, one would expect a
more rigid conformation for the primary binding loop.
Neither in the hirustasin–kallikrein complex, nor in the
free hirustasin structures do the temperature factors of
residues 24–29 indicate an increased flexibility. In the
hirustasin–kallikrein complex the inhibitor is not involved
in crystal contacts, and its conformation is determined
exclusively by the protease. In the structure of free hirus-
tasin this situation is, of course, different. The mainchain
of Val27 participates in the formation of crystal contact 1.
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Figure 6
Stereoview superposition of free hirustasin
(green), hirustasin in complex with kallikrein
(blue), and the N-terminal domain of antistasin
(magenta) [7]. The superposition is based on
Cα atoms of residues 24–52 of hirustasin and
residues 28–55 of antistasin. The N- and 
C-terminal subdomains are indicated.
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Figure 5
The root mean square deviation (rmsd) of the least-squares
superposition of all Cα atoms of the free and complexed hirustasin
structures. The superpositions are based on Cα atoms from (a) the
N-terminal subdomain (residues 8–26) and (b) the C-terminal
subdomain (residues 30–45).
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We conclude that the conformation of residues 24–29 seen
in the free and bound hirustasin structures, reflect the
propensity of these residues to form β-sheet interactions.
This loop might be flexible in solution and the target pro-
tease or the crystal lattice select different conformations. 
Comparisons between hirustasin and antistasin
A structural similarity between hirustasin and antistasin
was predicted from the sequence homology [1] and con-
firmed by the structural analysis of free antistasin [7]. The
antistasin structure contains a twofold internal repeat of
the hirustasin fold giving rise to four subdomains. We
refer to residues 7–27, 28–59, 60–71 and 82–110 as subdo-
mains Nn, Nc, Cn and Cc (where, for example, Cc is the
c-terminal subdomain of the C-terminal domain), respec-
tively. Figure 6 shows a superposition of the N-terminal
domain of antistasin onto both hirustasin structures. In all
structures, the N-terminal subdomains adopt different ori-
entations relative to the C-terminal subdomains. The
rmsds for the superposition of the separate subdomains
are 1.5 Å (residues 7–27), 1.4 Å (residues 28–55), 1.1 Å
(residues 60–71) and 1.7 Å (residues 82–110), indicating
that the subdomain folds are similar. The biological rele-
vance of these movements is unclear. We assume that the
relative subdomain orientations are a consequence of the
local environment in the crystal. In the structures of free
hirustasin and antistasin this environment is created by
the crystal lattice, but in the hirustasin–kallikrein complex
it is dominated by the cognate protease. It is likely that
the subdomains of antistasin rearrange in a similar fashion
to that observed in hirustasin when the inhibitor is bound
to a protease.
Figure 7 reveals that the conformation of the primary
binding loop of free hirustasin is more closely related to
that of free antistasin than to bound hirustasin. In partic-
ular, Val31 at P4 of free antistasin points in the same
direction as Val27 in free hirustasin. In the crystal struc-
ture of antistasin residues 28–33 are not involved in
crystal contacts and it can therefore be assumed that this
conformation is also present in solution. When antistasin
binds to a protease, this loop could undergo a similar con-
formational change to that of the hirustasin loop when
bound to kallikrein.
In antistasin, only subdomain Nc carries a functional
recognition site for the protease factor Xa. The necessity
for the conformational change could explain why only the
primary binding loop in subdomain Nc is recognised.
Although the corresponding loop in Cc (residues 82–90)
contains an arginine in P1, a disulphide in P2 and an
isoleucine in P4, it does not bind to factor Xa [22] because
the sequence between Cys82 and Cys88 carries a single
amino acid insertion. This insertion could render this site
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Figure 7
Superposition of C-terminal subdomains.
(a) Stereoview superposition of the C-terminal
subdomains of free (green) and complexed
(blue) hirustasin. The hydrogen bond in the
hirustasin–kallikrein complex between
His28 ND1 and Pro46 O (2.9 Å) is indicated
by a thin line. (b) Stereoview superposition of
the C-terminal subdomains of free hirustasin
(green) and subdomain Nc of antistasin
(magenta). Sidechain atoms are shown in
standard colours.
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inactive because the required loop conformation might be
energetically unfavourable.
Biological implications
In order to enable food uptake and digestion the saliva of
many leeches contains proteins that maintain the liquid
state of the ingested blood. Many of these proteins inhibit
proteases that are involved in the blood coagulation
cascade. A family of four closely related protease
inhibitors have been derived from the saliva of different
leeches: hirustasin, antistasin/ghilanten and guamerin
inhibit the proteases tissue kallikrein, factor Xa and elas-
tase, respectively. As these inhibitors are secreted they
have to combine a high selectivity for the target protease
with the ability to resist harsh environmental conditions.
Comparisons of the structure of the hirustasin–kallikrein
complex with the structure of the free hirustasin, pre-
sented here, reveals that hirustasin consists of two sub-
domains that are stabilised by five disulphide bridges.
Upon binding to kallikrein the relative orientation of the
subdomains changes. This movement is accompanied by
a 180° rotation of the primary binding loop and a
cis/trans-isomerisation of Pro47 from the secondary
binding loop. The sequence homology within this
inhibitor family implies that similar structural rearrange-
ments can be anticipated for all members of the family.
Materials and methods
Data collection and processing
Details on the expression, purification and crystallisation have been
described previously by Di Marco et al. [23]. Crystals belonged to the
space group P43212. The exact unit-cell parameters and statistics on
the data that were used for structure determination and refinement are
given in Table 1. For data collection at 100K, the crystals were soaked
for 2 h in a mixture of 100 µl reservoir solution and 50 µl glycerol. The
crystals were shock frozen in a cold nitrogen stream. Data sets native 1
and native 2 were collected on MAR image plate detector systems and
processed using the program MARXDS/MARSCALE [24]. The data
set for the gold derivative was collected on a Fast area detector system
and processed with the program MADNESS [25].
Structure refinement
Independent refinements were performed on the 1.2 Å low tempera-
ture data and the 1.4 Å room temperature data, starting with a model
built using the peak list of the 1.2 Å ab initio map. The structures
were refined against F2 with no low resolution cut-off using the
program SHELXL-97 [26]. Sigma-A maps [16] were displayed using
the program O [27] for manual editing of the structure. Engh and
Huber [28] geometric restraints were employed. Planarity restraints
were applied to peptide bonds and aromatic sidechains. Similarity
restraints were used for the isotropic displacement parameters of
atoms closer than 1.7 Å to one another (including atoms belonging to
different components of disordered groups). A two-parameter diffuse
solvent model [29] was refined throughout, and antibumping
restraints were generated automatically. Hydrogen atoms were
included in geometrically calculated positions and refined using a
riding model without introducing further parameters; the final 1.2 Å
model contains 52 water sites and two partially occupied sulphate
sites. Before refinement, 5% of the data were reserved for calculation
of the Rfree value [30]. Anisotropic refinement against the 1.2 Å data
led to a drop of 3% in the working R factor and Rfree. The 1.4 Å data
set was refined isotropically, except for the sulphur atoms in the cys-
teine residues. For the anisotropic atoms, rigid bond restraints were
applied to the differences in mean square displacement amplitudes
along 1,2 interatomic vectors. The anisotropic solvent atoms were
restrained weakly to be approximately isotropic. Data collection and
refinement parameters are summarised in Table 3. Figures were
drawn with the programs MOLSCRIPT [31], BOBSCRIPT [32],
SHELXTL [33] and SHELXPRO [26]. 
Accession numbers
The atomic coordinates and structure factors for hirustasin have been
deposited with the Brookhaven Protein Data Bank, with accession
codes 1BX7 and 1BX7SF, respectively.
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